What will it mean for asthmatic patients as GSK stops production of Flovent inhalers?

In 2024, users of the well-known corticosteroid inhalers Flovent HFA or Flovent Diskus will have to move to a new medicine to manage their asthma as GlaxoSmithKline (GSK), the company that makes them has decided to stop its production.

According to GSK, they would instead create an approved generic version using the same device design…